By CRAIG HAUBEN

Ask anyone outside healthcare who resists clinical AI and you’ll get a confident answer. The older doctors. The ones who spent thirty years building expertise and now see a machine coming for it. The story writes itself, which should have been the first clue it was wrong.

I’ve spent thirty years in healthcare, and I now run a company that builds and runs AI inside provider and payer organizations. At Clutch we use AI’s data analysis to solve engagement challenges. Who is the patient today? What message will land with them? When do they want to read it? Get those right and you can drive the kind of sustained behavior change that moves clinical outcomes like drug adherence, care plan adherence, and gap closure.

So I’m not working from theory. I watch this land in real workflows, and here’s what I see. The clinicians most enthusiastic about AI are usually the ones who’ve done the job the longest. The resistance comes from somewhere else. If you run a health system, that difference should change how you plan your next deployment.

Start with the adoption numbers, because they already break the resistance story. The AMA’s latest survey found four in five physicians now use AI in practice, up from 38 percent in 2023. That’s not a profession digging in against a threat. That’s a profession that found something useful.

Now the veterans. A doctor with three decades in a specialty can see, better than anyone, what these systems are good at. Pattern recognition at scale. Catching the thing that should have been flagged two visits ago. Surfacing what was already sitting in the data: the missed finding in last year’s imaging, the lab trend across eighteen months that looked unremarkable one value at a time, the three ED visits in six weeks nobody had the time to connect.

This isn’t hypothetical. The Nature study of Google’s breast cancer screening system showed a 9.4 percent drop in false negatives for US patients, the cancers human readers missed. The largest NHS evaluation to date, across 175,000 women, found AI caught more invasive cancers with fewer false positives than human readers. The harm these systems go after, information that existed and never got connected, is one experienced clinicians know cold. They’ve spent careers watching its absence hurt people.

Here’s one from our own work. We’re working with a national government programs payer on some of their hardest members to engage, the high intensity ones who need contact four or five times a day for six months or more. We got engagement to 95 percent, measured by the customer, and adherence to 93 percent. The result was a 0.8 average drop in HbA1c and an 18 percent reduction in symptoms.

When a system takes the mechanical load off so the judgment work gets more attention, the thirty-year clinician doesn’t feel threatened. They feel relieved. Their expertise is the judgment, not the data retrieval, and they’ve always known the difference.

Now look at where the fear actually lives. It comes from the middle.